Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Houmanfarma is 0.4% (very low). The 2025 annual accounts show equity of €331k and a net result of €51k. The company has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Filing behaviour
From the deposit records, complete market-wide| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | 25-08-2026 | 25 d late | 2026-00422504 |
| 31-12-2024 | 31-07-2025 | 12-08-2025 | 12 d late | 2025-00371398 |
| 31-12-2023 | 31-07-2024 | 21-08-2024 | 21 d late | 2024-00355369 |
| 31-12-2022 | 31-07-2023 | 24-08-2023 | 24 d late | 2023-00348225 |
| 31-12-2021 | 31-07-2022 | 25-08-2022 | 25 d late | 2022-20313946 |
| 31-12-2020 | 31-07-2021 | 24-08-2021 | 24 d late | 2021-51700556 |
| 31-12-2019 | 31-07-2020 | 19-08-2020 | 19 d late | 2020-42100088 |
| 31-12-2018 | 31-07-2019 | 16-08-2019 | 16 d late | 2019-46800440 |
| 31-12-2017 | 31-07-2018 | 21-08-2018 | 21 d late | 2018-48000157 |
| 31-12-2016 | 31-07-2017 | 23-08-2017 | 23 d late | 2017-46200383 |
Source: the National Bank's deposit records, as we have ingested them. NOTE: our copy has a gap across June to August 2026, missing roughly 220,000 deposits; for July we hold 15,605 of about 137,000 expected. A year whose deadline falls in that window shows as not confirmed, not as not filed. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsAdministrative Flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB · 2025| Fiscal year | 2025 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €148k |
| Net profit | €51k |
| Cash flow | €122k |
| Staff costs | €40k |
| Income taxes | €19k |
| Dividends | - |
| Total assets | €701k |
| Equity | €331k |
| Debt | €370k |
| of which ≤ 1y | €327k |
| of which > 1y | €43k |
| Working capital | €105k |
| Employees (FTE) | 0.8 |
| 2025 | |
|---|---|
| Current ratio | 1.32 |
| Quick ratio | 0.49 |
| Working capital ratio | 14.9% |
| Solvency | 47.2% |
| Debt / equity | 1.12 |
| Long-term debt ratio | 0.13 |
| Interest coverage | 21.10 |
| Gross margin | - |
| Net margin | - |
| ROA | 7.2% |
| ROE | 15.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €701k |
| Fixed assets | 21/28 | €269k |
| Tangible fixed assets | 22/27 | €269k |
| Financial fixed assets | 28 | €0 |
| Current assets | 29/58 | €432k |
| Stocks & contracts in progress | 3 | €270k |
| Amounts receivable within one year | 40/41 | €122k |
| Cash & bank | 54/58 | €33k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €701k |
| Equity | 10/15 | €331k |
| Contributions / capital | 10/11 | €62k |
| Reserves | 13 | €269k |
| Amounts payable | 17/49 | €370k |
| Amounts payable after one year | 17 | €43k |
| Amounts payable within one year | 42/48 | €327k |
| Trade debts payable within one year | 44 | €229k |
| Income statement | ||
| Gross operating margin | 9900 | €189k |
| Operating result | 9901 | €77k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €70k |
| Income taxes | 67/77 | €19k |
| Net result for the period | 9904 | €51k |
| Result to be appropriated | 9905 | €51k |
Health barometer
FY 2025 · computedThe full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Structure & network
Locations & real estate
Registered office
from the Crossroads BankThis address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Boechtstraat 101860 MeiseEstablishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23050F0355/00K000 | Flanders | 793 m² | 1 · 194 m² | 12.3 m · 2 fl. |
Publications
Lifecycle & Insolvency Signals
Belgian State Gazette · acts
That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.
Analysis
Financial profile
4 of 5 axes measuredStrong profile, led by stability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector and regionCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | Houmanfarma |